RWM
MRNA icon

Rialto Wealth Management’s Moderna MRNA Stock Holding History

Rialto Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38K Buy
34
+14
+70% +$724 ﹤0.01% 1057
2026
Q1 		$1.02K Buy
20
+17
+567% +$793 ﹤0.01% 1101
2025
Q4 		$89 Hold
3
– – ﹤0.01% 1645
2025
Q3 		$78 Hold
3
– – ﹤0.01% 1647
2025
Q2 		$83 Buy
+3
New +$79 ﹤0.01% 1561
2025
Q1 		– Sell
-2
Closed -$84 – 1002
2024
Q4 		$84 Buy
+2
New +$96 ﹤0.01% 517

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Rialto Wealth Management's MRNA Position: Q2 2026 in Review

Rialto Wealth Management increased its Moderna (MRNA) stake by 70% in Q2 2026, buying an estimated $724 and bringing the position to 34 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

Rialto Wealth Management first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Rialto Wealth Management held 34 shares of Moderna worth $2.38K as of Q2 2026.
  • Rialto Wealth Management bought 14 Moderna shares in Q2 2026, an estimated $724.
  • Moderna made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1057 holding.
  • Rialto Wealth Management first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.